PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV (Q30401566)

21 June 2017

title

PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV (English)

1 reference

https://api.crossref.org/works/10.1007/S12250-011-3183-Z

29 November 2024

0 references

1 reference

Hui-min Yan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21468931

29 November 2024

Wei-wei Gai

1 reference

21 June 2017

Yan Zhang

1 reference

21 June 2017

Di-han Zhou

1 reference

21 June 2017

Yao-qing Chen

1 reference

21 June 2017

Jing-yi Yang

1 reference

21 June 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21468931

29 November 2024

publication date

7 April 2011

1 reference

full work available at URL

21 June 2017

https://link.springer.com/content/pdf/10.1007/s12250-011-3183-z.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21468931

https://europepmc.org/articles/PMC7091335

29 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21468931

https://europepmc.org/articles/PMC7091335?pdf=render

29 November 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21468931

http://link.springer.com/content/pdf/10.1007/s12250-011-3183-z.pdf

29 November 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S12250-011-3183-Z

http://link.springer.com/article/10.1007/s12250-011-3183-z/fulltext.html

29 November 2024

1 reference

https://api.crossref.org/works/10.1007/S12250-011-3183-Z

http://link.springer.com/content/pdf/10.1007/s12250-011-3183-z

29 November 2024

1 reference

https://api.crossref.org/works/10.1007/S12250-011-3183-Z

29 November 2024

1 reference

21 June 2017

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

81-94

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Cytokines as adjuvants for the induction of anti-human immunodeficiency virus peptide immunoglobulin G (IgG) and IgA antibodies in serum and mucosal secretions after nasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal immunity and tolerance: relevance to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Aetiology: Koch's postulates fulfilled for SARS virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Interaction of antigens and antibodies at mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Pathogenesis of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Immunization against bacterial diseases of the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Association of HLA class I with severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Intracellular neutralization of virus by immunoglobulin A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal vaccines: the promise and the challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Mucosal Tolerance: A Two-Edged Sword to Prevent and Treat Autoimmune Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12250-011-3183-Z

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity

21 January 2018

1 reference

12 December 2020

The effect of interferon on rabies infection of animals

1 reference

12 December 2020

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase

1 reference

12 December 2020

Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

1 reference

12 December 2020

An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice

1 reference

12 December 2020

PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA

1 reference

12 December 2020

Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells

1 reference

12 December 2020

Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans

1 reference

12 December 2020

Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses

1 reference

12 December 2020

Poliomyelitis in the United States: the final chapter?

1 reference

12 December 2020

Immunologic‐mediated Protection of Trypanosoma congolense‐Infected Mice by Polyribonucleotides

1 reference

12 December 2020

Texas Reports on Biology and Medicine

526

G. M. Baer

1981

1 reference

https://api.crossref.org/works/10.1007/S12250-011-3183-Z

29 November 2024

Identifiers

1 reference

Dimensions Publication ID

21 June 2017

1020760771

0 references

PMC publication ID

7091335

0 references

1 reference